子宫内膜不典型增生及早期子宫内膜癌患者保守治疗后IVF/ICSI助孕结局OA
Outcomes of females with atypical endometrial hyperplasia/endometrial carcinoma un-dergoing IVF/ICSI and obstetric outcomes after conservative treatment
目的:探讨子宫内膜不典型增生(AEH)及早期子宫内膜癌(EC)患者接受体外受精/卵胞浆内单精子注射(IVF/ICSI)治疗后的助孕结局及围产结局.方法:采用回顾性队列分析,纳入2018 年1 月至2024 年12 月期间在郑州大学第三附属医院生殖中心首次接受 IVF/ICSI 治疗的 AEH/EC 患者,设为 AEH/EC 组(48 例);同期首次接受 IVF/ICSI 治疗的无子宫内膜病变患者设为对照组(14948 例).根据年龄、不孕年限、不孕类型、不孕原因、窦卵泡计数(AFC)、体质量指数(BMI)及取卵时间,按 1∶3 比例采用倾向性评分匹配(PSM),最终纳入 AEH/EC 组46 例、对照组134 例.比较两组患者的基础资料、IVF/ICSI 助孕指标、新鲜周期移植的临床妊娠率、累积妊娠率、累积活产率及母婴结局.结果:PSM 前,与对照组相比,AEH/EC 组患者年龄更大[(32.79±3.96)岁 vs(31.13±4.19)岁,P=0.006)],不孕年限长[(5.27±3.58)年 vs(3.57±2.70)年,P=0.000],原发不孕比例高(77.08%vs 47.87%,P=0.000),AFC 少[(13.48±8.05)个 vs(18.23±9.44)个,P=0.000],BMI 高[(26.79±4.31)kg/m2 vs(23.83±3.43)kg/m2,P=0.000].AEH/EC 组不孕原因主要为卵巢因素(50.00%)、输卵管因素(25.00%),对照组不孕原因主要为输卵管因素(53.04%)、男方因素(19.76%),差异有统计学意义(P=0.000).PSM 后,两组患者的基本情况(年龄、不孕年限、不孕类型、AFC、BMI、不孕原因)差异均无统计学意义(均 P>0.05).与对照组相比,AEH/EC 组的 IVF/ICSI 指标中,促性腺激素(Gn)使用时间短(10.16±2.51 vs11.35±2.81,P=0.014)、人绒毛膜促性腺激素(hCG)注射日内膜厚度更薄(7.88±2.47 vs 11.35±2.81,P=0.000)、优质胚胎率高(50.94%vs 48.17%,P=0.000)、囊胚形成率低(47.47%vs 62.22%,P=0.000).PSM 后,AEH/EC组的达妊娠时间长于对照组(214.39±213.68 vs 136.01±86.37,P=0.008),但两组累积妊娠率、累积活产率等指标差异均无统计学意义(均 P>0.05).两组在分娩方式、分娩孕周、胎儿出生体质量及妊娠期并发症发生率方面差异均无统计学意义(均 P>0.05).至末次随访,AEH/EC 组有 2 例复发,复发率为 4.17%(2/48).结论:AEH/EC 患者通过IVF/ICSI 可获得满意的助孕结局,且未增加早产、低出生体质量儿等不良围产结局的风险.
Objective:To explore the impact of atypical endometrial hyperplasia(AEH)and early endometrial carcinoma(EC)on the pregnancy and perinatal outcomes of in vitro fertilization/intracytoplasmic sperm injectionoutcomes(IVF/ICSI)after conservative treat-ment.Methods:48 patients with AEH/EC and 14948 women with no evidence of endometrial abnormality,who underwent their first autologous oocytes'retrieval cycles of IVF/ICSI at the Reproductive Center of the Third Affiliated Hospital of Zhengzhou University from January 2018 to December 2024,were retrospectively enrolled.The two groups were matched at a ratio of 1:3 based on age,infertility duration,infertility type,infertility cause,antral follicle count(AFC),body mass index(BMI),and oocyte retrieval time using propensity score matching(PSM).The AEH/EC group included 46 patients,and the control group included 134 patients.The basic conditions,IVF/ICSI indicators,clinical pregnancy rate in fresh cycles,cumulative pregnancy rate,cumulative live birth rate,and the perinatal outcomes of the two groups were analyzed.Re-sults:Before PSM the AEH/EC group was older(32.79±3.96 vs 31.13±4.19,P=0.006),had a longer infertility duration(5.27±3.58 vs 3.57±2.70,P=0.000),a higher proportion of primary infertility(77.08%vs 47.87%,P=0.000),a lower AFC(13.48±8.05 vs 18.23±9.44,P=0.000),and a higher BMI(26.79±4.31 vs 23.83±3.43,P=0.000)compared with the control group.The main causes of infertility in the AEH/EC group were ovarian factors(50%)and tubal factors(25.00%),while they were tubal factors(53.04%)and male fac-tors(19.76%)in the control group,and the differences were statistically significant(P=0.000).After PSM,there were of no significant differences in the basic conditions(age,infer-tility duration,infertility type,AFC,BMI,and infertility cause)between the two groups(all P>0.05).Compared with the control group,the AEH/EC group had a shorter duration of gonado-tropins(Gn)used(10.16±2.51 vs 11.35±2.81,P=0.014),thinner endometrium on hCG day(7.88±2.47 vs 11.35±2.81,P=0.000),a higher rate of high-quality embryos(50.94%vs 48.17%,P=0.000),and a lower blastocyst formation rate(47.47%vs 62.22%,P=0.000).After PSM,the time to pregnancy in the AEH/EC group was longer than that in the control group(214.39±213.68 vs 136.01±86.37,P<0.05),but there were no significant differences in cumulative pregnancy rate,cumulative live birth rate,delivery mode,gestational age at deliv-ery,birth weight and the incidence of pregnancy complications between the two groups(all P>0.05).By the end of the last follow-up,the recurrence rate of the AEH/EC group was 4.17%(2/48).Conclusion:Satisfactory pregnancy outcomes can be achieved in patients with AEH/EC through IVF/ICSI without increasing the risk of preterm birth,low birth weight.
李静;万留霞;乔洪武;张萌;李嘉恒;任炳楠;刘书娟;管一春
郑州大学第三附属医院生殖中心,郑州 450052郑州大学第三附属医院生殖中心,郑州 450052郑州大学第三附属医院生殖中心,郑州 450052郑州大学第三附属医院生殖中心,郑州 450052郑州大学第三附属医院生殖中心,郑州 450052郑州大学第三附属医院生殖中心,郑州 450052郑州大学第三附属医院生殖中心,郑州 450052郑州大学第三附属医院生殖中心,郑州 450052
医药卫生
子宫内膜不典型增生早期子宫内膜癌体外受精卵胞浆内单精子注射助孕结局
Atypical endometrial hyperplasiaEndometrial carcinomaIn vitro fertili-zationIntracytoplasmic sperm injectionsPregnancy outcomes
《现代妇产科进展》 2026 (5)
336-341,6
河南省医学科技攻关计划联合共建项目(No:LHGJ20210461)
评论